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https://doi.org/10.1016/j.celrep.2020.107696SUMMARYThe flat bones of the skull are densely innervated during development, but little is known regarding their role
during repair. We describe a neurotrophic mechanism that directs sensory nerve transit in the mouse
calvaria. Patent cranial suture mesenchyme represents an NGF (nerve growth factor)-rich domain, in which
sensory nerves transit. Experimental calvarial injury upregulatesNgf in an IL-1b/TNF-a-rich defect niche, with
consequent axonal ingrowth. In calvarial osteoblasts, IL-1b and TNF-a stimulateNgf and downstreamNF-kB
signaling. Locoregional deletion of Ngf delays defect site re-innervation and blunted repair. Genetic disrup-
tion of Ngf among LysM-expressing macrophages phenocopies these observations, whereas conditional
knockout ofNgf among Pdgfra-expressing cells does not. Finally, inhibition of TrkA catalytic activity similarly
delays re-innervation and repair. These results demonstrate an essential role of NGF-TrkA signaling in bone
healing and implicatemacrophage-derivedNGF-induced ingrowth of skeletal sensory nerves as an important
mediator of this repair.INTRODUCTION
The formation and regeneration of craniofacial bones of the
mammalian skeleton requires the action of both intrinsic and
extrinsic inductive factors from multiple cell types (Ferguson
and Atit, 2019; Lenton et al., 2005; Levi et al., 2012; Pan et al.,
2013). Unlike the appendicular skeleton, intramembranous cra-
nial bones form and are healed without a cartilaginous template,
by condensations of mesenchymal progenitor cells. During
development, these mesenchymal progenitor cells migrate to
positions between the brain and surface ectoderm. There, the
cells condense and differentiate along an osteogenic lineage
that directly generates osteoid that subsequently mineralizes.
As membranous bones expand, ossification proceeds in an or-
dered manner from the skull base toward the skull apex, with
bones meeting in the organism’s midline to form the cranial su-
ture complex. Bounded by periosteum (PO) above and the outer
meningeal layer below, the cranial suture mesenchyme is a
reservoir of skeletal progenitor cells that maintains homeostasis
of the uninjured skull or participates in healing the skull after
injury (Maruyama et al., 2016; Zhao et al., 2015). Despite the
immediate anatomic proximity of the skull and nervous system,
little is understood of how neuroskeletal intercommunication
informs bone healing after injury.This is an open access article under the CC BY-NMany of the cellular events following bone injury resemble
those that occur during skeletal development. One notable dif-
ference is the sensation of acute pain, which is transmitted by
afferent sensory nerves that innervate the appendicular skeleton
(Bjurholm et al., 1988; Castañeda-Corral et al., 2011). In this
pathway, nerve growth factor (NGF) transmits nociceptive sig-
nals either by directly activating tropomyosin receptor kinase A
(TrkA)+ sensory nerves or through indirect mechanisms, which
intensify alternate nociceptive pathways (Mantyh, 2014; Pezet
and McMahon, 2006). In addition to pain sensation, a large
body of literature supports an evolutionarily conserved role of
TrkA sensory nerves in organogenesis and tissue regeneration
(Kumar and Brockes, 2012). For example, sensory or motor
neurons are known to drive the subsequent assembly of vascular
and tissue components that are responsible for the ability of the
starfish and certain amphibians to regenerate entire appendages
(Kumar and Brockes, 2012). However, the role of NGF-respon-
sive nociceptive fibers in influencing mammalian bone tissue
repair is not yet known.
In comparison with the long bones, in which nerve fiber fre-
quency has been well defined (Bjurholm et al., 1988; Grönblad
et al., 1984; Hohmann et al., 1986; Mach et al., 2002), the
nerve fibers that innervate the skull are less well understood.
Skull-associated nerve fibers are found on both theCell Reports 31, 107696, May 26, 2020 ª 2020 The Author(s). 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Ngf Expression Domains and Innervation of the Uninjured Calvarium
(A) Tile scan of the uninjured parietal bone and sagittal suture (center) in the NGF-eGFP reporter animal.
(B–D) High-magnification images of cranial sutures within NGF-eGFP reporter animals, including (B) patent sagittal suture, (C) patent coronal suture, and (D) fused
portion of posterofrontal suture.
(E) NGF reporter activity within the intact frontal bone. PO, periosteum; DM, dura mater.
(F and G) Immunohistochemical staining (appearing red) within the sagittal suture of NGF-eGFP reporter animals, including (F) Gli1 and (G) Axin2.
(H) PGP9.5 whole-mount image of the patent sagittal suture. White dashed lines indicate margins of the patent suture, imaged from the endocranial aspect.
(I and J) TUBB3 (beta III tubulin) whole-mount images of patent cranial sutures, including the (I) sagittal and (J) coronal suture. White dashed lines indicate margins
of the patent suture, imaged from the endocranial aspect.
(K and L) Immunohistochemical staining typifying nerve fibers within the sagittal suture, including (K) CGRP+ peptidergic fibers (appearing red) (L) and TH+
sympathetic fibers (appearing cyan). White dashed lines indicate margins of the patent suture, imaged from the endocranial aspect.
(M) Tile scan of TUBB3+ nerve fibers in the uninjured frontal bone. TUBB3+ nerve fibers appear green.
(N–P) Cross-sectional images of nerve fibers within patent cranial sutures using pan-neuronal Thy1-YFP transgenic reporter animals. Thy1-YFP reporter activity
within patent cranial sutures, including (N) sagittal, (O) coronal, and (P) lambdoid sutures. Thy1-YFP reporter activity appears green.
DAPI counterstain appears blue in all images. Representative images shown from n = 4 mice. All white scale bar, 50 mm. See also Figure S1.
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OPEN ACCESSendocranial and ectocranial surfaces of the calvaria (Alberius
and Skagerberg, 1990; Silverman and Kruger, 1989) and
have been studied in connection with migraine headaches
(Kosaras et al., 2009). These nerve-enriched coverings of
calvarial bone, such as dura and PO, are essential for coordi-
nated bone repair (Doro et al., 2017; Levi et al., 2011; Warren
et al., 2003). Yet, and despite the immediate anatomic prox-
imity of the skull and nervous system, little is understood of
how neuroskeletal intercommunication informs bone healing
after injury.
In this study, we characterized the innervation of mouse
cranial bone and examined the role of these nerves in a mouse
model of bone injury. Our results reveal a neurotrophic mecha-
nism that directs sensory nerve transit in cranial bone repair.2 Cell Reports 31, 107696, May 26, 2020RESULTS
Ngf Expression in Cranial Suture Mesenchyme
Coincides with Sensory Nerve Transit
Ngf-expressing cells in the uninjured skull were identified using a
previously validated NGF-eGFP reporter animal (Figures 1A–1G)
(Kawaja et al., 2011). NGF reporter activity was abundant in
mesenchymal cells of all patent cranial sutures (Figures 1A–
1C), but not the already fused posterofrontal suture (Figure 1D).
Immunocytochemistry performed on parallel sections showed
that putative sutural stem cell markers were co-expressed
with NGF reporter activity, such as the zinc finger transcription
factor Gli1 (Figure 1F) (Zhao et al., 2015) and the Wnt regulatory
protein Axin2 (Figure 1G) (Maruyama et al., 2016). Within the
Figure 2. NGF-eGFP Reporter Activity following Calvarial Bone Injury
NGF-eGFP reporter animals were subjected to a circular, full-thickness frontal bone defect (1.8 mm in diameter).
(A–E) mCT reconstructions of the defect site in a top-down view (left) and coronal cross-sectional images (right) among (A) uninjured frontal bones and (B–E) d3–
d28 post-injury. Margins of original defect are indicated by dashed black or red lines. Black scale bar, 500 mm; white scale bar, 200 mm.
(F–J) Representative tile scans (left) and high-magnification images (right) of NGF-eGFP reporter activity in the calvarial defect site at serial time points, including
(F) uninjured frontal bones and (G–J) d3–d28 post-injury. Reporter activity appears green, while nuclear counterstain appears blue. Uninjured control is shown for
comparison. White arrowheads indicate margins of defect site. Dashed white lines indicate healing bone edge. White scale bar, 50 mm.
(K) Quantification of relative NGF-eGFP reporter activity from d3–d28 post-injury.
(L–N) Immunohistochemical staining (appearing red) within the defect area of NGF-eGFP reporter animals, including (L) PDGFRa (platelet-derived growth factor
receptor a), d3 post-injury; (M) F4/80, d3 post-injury; and (N) osteocalcin (OCN), d14 after injury. In graphs, each dot represents a single animal; n = 3 animals per
time point. White scale bar, 50 mm. Data are represented as mean ± SD.
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OPEN ACCESSbone, NGF-eGFP reporter activity was detected at lower levels
in the overlying PO and underlying dura mater (DM) (Figure 1E)
but was absent in cortical osteocytes.
To identify peripheral nerves within the uninjured skull, we per-
formed immunohistochemical staining using the pan-neuronal
markers protein gene product 9.5 (PGP9.5) (Figure 1H) and
beta III tubulin (TUBB3) (Figures 1I, 1J, and 1M). In whole-mount
preparations, PGP9.5+TUBB3+ nerve fibers were observed par-
allel to patent sagittal and coronal sutures (Figures 1H–1J). In the
sagittal suture, the majority of the nerves were positive for CGRP
(Figure 1K), but a smaller proportion expressed the sympathetic
nerve marker tyrosine hydroxylase (TH) (Figure 1L). In general,
uninjured calvarial bones showed comparatively less frequent
nerve fibers at the dural and periosteal surfaces in whole-mount
preparations (Figure S1). Imaging of coronal sections of the un-
injured calvaria showed a clear enrichment of TUBB3+ nerve fi-
bers within the patent cranial sutures (Figure 1M), a pattern
confirmed in sections from Thy1-YFP pan-neuronal reporter an-
imals (Figures 1N–1P). Here, abundant YFP-positive nerve fibers
are seen traversing or terminating within patent sagittal, coronal,
and lambdoid sutures. In contrast, little or no YFP fluorescence
was observed at sites of fused calvarial sutures (not shown).Ngf Is Acutely Upregulated following Calvarial Bone
Injury
To examine the role of skeletal sensory nerves in cranial bone
repair, we first determined the temporo-spatial domains of Ngf
expression in the NGF-eGFP reporter animal subjected to
experimental injury. In this procedure a small (1.8 mm), circular,
full-thickness defect was surgically created in the frontal bone,
and re-ossification was followed over a 4 week period using
microcomputed tomography (mCT) (Figures 2A–2E). Within the
uninjured bone, patchy, weak NGF reporter was present within
the PO and DM, but not in cortical osteocytes (Figure 2F). At
day 3 (d3) post-injury, themajority of cells within the fibro-inflam-
matory defect were NGF reporter positive, most notably adja-
cent to the injured bone (Figure 2G). At later time points corre-
sponding to re-ossification, the majority of eGFP reporter
activity was localized to bone-lining cells along the re-growing
defect edges (d7 and 14; Figures 2H and 2I). At later times,
NGF reporter activity waned but was still present in bone-lining
cells (d28; Figure 2J). At all time points, cortical osteocytes
remained NGF reporter negative. Semiquantitative analysis of
relative NGF-eGFP reporter activity showed a robust (approxi-
mately 50-fold) increase in NGF reporter activity at 3 daysCell Reports 31, 107696, May 26, 2020 3
Figure 3. Inflammatory Cytokines Induce
Ngf Expression within Calvarial Osteoblasts
(A andB) Immunohistochemistry for IL-1b, appearing
red, on the calvarial injury site within NGF-eGFP re-
porter sections at (A) d3 and (B) d7post-injury.Green
arrowheads indicate bone-lining eGFP reporter ac-
tivity, while red arrowheads indicate immunoreac-
tivity within the defect site. White dashed lines
indicate bone edges. Inset demonstrates immuno-
reactivity among uninjured calvarial bone. White
scale bar, 50 mm; purple scale bar, 20 mm.
(C and D) Immunohistochemistry for TNF-a, ap-
pearing red, on the calvarial injury site within NGF-
eGFP reporter sections at (C) d3 and (D) d7 post-
injury. Green arrowheads indicate bone-lining eGFP
reporter activity, while red arrowheads indicate
immunoreactivity within the defect site. White
dashed lines indicate bone edges. Inset demon-
strates immunoreactivity among uninjured calvarial
bone. White scale bar, 50 mm; purple scale bar,
20 mm.
(E) Ngf expression among calvarial osteoblasts 48 h
after treatment with recombinant IL-1b or TNF-a,
assessed using qRT-PCR.
(F) eGFP expression among NGF-eGFP-derived
calvarial osteoblasts 48 h after treatment with IL-1b
(1 ng/mL) or TNF-a (25 ng/mL), assessed using qRT-
PCR.
(G) NF-kB signaling among calvarial osteoblasts 15–
60min after treatment with IL-1b (1 ng/mL) or TNF-a
(25 ng/mL), assessed using western blot.
All experiments were performed in triplicate. Repre-
sentative histologic images are from n = 3 mice per
time point. yp < 0.05 and yyp < 0.01 in comparison
with control. Data are represented as mean ± SD.
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OPEN ACCESSfollowing injury (Figure 2K). NGF reporter activity remained
elevated over baseline throughout the study period but gradually
waned to a value 5.4-fold over uninjured calvaria by the d28
study endpoint (Figure 2K).
Immunohistochemical staining of NGF-eGFP reporter sec-
tions was next performed to delineate Ngf-expressing cell types
within the early bone defect niche (Figures 2L and 2M). At early
time points post-injury, PDGFRa (platelet-derived growth factor
receptor a)+ mesenchymal cells showed high co-expression
with eGFP reporter activity (Figure 2L, d3 post-injury). In addi-
tion, F4/80+macrophages also showed substantial NGF reporter
activity (Figure 2M, d3 post-injury). At later time points after ossi-
fication, we had observed bone-lining cells with the predominant
cell type with eGFP reporter activity. To confirm this, osteocalcin
(OCN) immunohistochemistry was performed and demonstrated
that bone-lining OCN+ osteoblasts were the primary source of
Ngf during later stages of defect repair (Figure 2N, d14 shown).Inflammatory Signals Drive Ngf Expression in Injured
Calvaria
A universal response to tissue injury is the induction of pro-in-
flammatory cytokines, which initiate key signaling cascades
critical to tissue repair. To determine the possible role of inflam-
matory signals on Ngf expression in response to calvarial
injury, inflammatory cytokine expression was assessed using
immunohistochemistry within NGF-eGFP reporter sections.4 Cell Reports 31, 107696, May 26, 2020Robust immunoreactivity for both IL-1b and TNF-a corre-
sponded to domains of NGF reporter activity at d3 post-injury
(Figures 3A and 3C, appearing yellow). At d7, less prominent
immunoreactivity for IL-1b and TNF-a was observed, primarily
in the non-ossified defect site (Figures 3B and 3D, appearing
red), while NGF reporter activity had by this point become
more restricted to bone-lining osteoblasts (Figures 3B and 3D,
appearing green). To determine whether these cytokines
directly induced Ngf expression, mouse calvarial cells were
exposed to recombinant IL-1b or TNF-a, and Ngf transcripts
were assayed using qPCR. Both cytokines induced Ngf mRNA
expression in a dose-dependent manner (Figure 3E). Further-
more, both IL-1b and TNF-a induced eGFP reporter in mesen-
chymal cells isolated from a mouse carrying the NGF-eGFP re-
porter allele (Figure 3F). These changes were associated with
induction of NF-kB signaling activation among mouse calvarial
cells (Figure 3G).Re-innervation of the Calvarial Bone Defect Follows
Acute Ngf Upregulation
A robust and acute rise in Ngf expression after calvarial injury
would be expected to result in a prominent localized ingrowth
of skeletal-associated nerve fibers. To test this idea, the tem-
poro-spatial domains of calvarium-associated nerve fibers
were next characterized over the same 28 day time interval after
bone injury (Figure 4). For this purpose, C57BL/6Jwild-typemice
Figure 4. Re-innervation during Calvarial Bone Defect Repair
(A–E) Representative whole-mount tile scans (left) and high-magnification images (right) of TUBB3 (beta III tubulin)-stained calvarial defects from (B–E) d3 to d28
post-injury. (A) Uninjured control shown as a comparison. TUBB3+ nerve fibers appear green. Dashed white circles indicates margins of defect. White asterisks
indicate midline suture. Upper right-hand inset depicts negative control without primary antibody application. White scale bar, 200 mm.
(F–I) Tile scan image (F) and higher magnification images of TUBB3 immunohistochemical staining of nerve fibers, including (G and I) TUBB3+ nerves at the
margins of the defect and (H) center of the defect, d14 post-injury. Asterisk in tile scan indicates the midline suture. White arrowheads indicate sites of prominent
re-innervation adjacent to healing bone defect edges.
(J–L) Immunohistochemical staining typifying nerve fibers within the calvarial defect at d14 post-injury, including (J) the pan-neuronal marker protein gene product
9.5 (PGP9.5), (K) the peptidergic fiber marker calcitonin gene-related peptide (CGRP), and (L) the sympathetic marker tyrosine hydroxylase (TH).
Representative images are from n = 3 mice per time point. White scale bar, 50 mm. See also Figure S2.
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immunohistochemical staining with the pan-neuronal marker
TUBB3 (Figures 4A–4E). Whole-mount imaging of the endocra-
nial aspect of the uninjured calvaria confirmed our prior
findings, including a high density of nerve fibers running along
the endocranial surface of the midline suture (denoted by an
asterisk) and relatively less prominent nerve fibers forming a
meshwork across the calvarial bone (Figure 4A). Upon calvarial
bone injury, re-innervation begins on the medial edge of the
defect as soon as d3 (Figure 4B), and progressive axonal
ingrowth, sprouting, and ingrowth occur over the time course
of calvarial repair (Figures 4C–4E). Coronal sections of the
calvaria were then visualized by TUBB3 immunohistochemical
staining in order tomore precisely define the spatial relationships
between nerve fibers within the injury site and the regenerating
bone (Figures 4F–4I). A representative tile scan of the defectshowed that the nerve fibers were most conspicuously the lead-
ing bone edges of the healing defect (Figure 4F), which appeared
in continuity with nerve fibers within the dura, PO, and adjacent
patent suture. High-magnification images confirmed these
findings, with prominent small-caliber dendrites wrapping along
the healing bone edges (Figures 4G and 4I) and less conspicuous
nerve fibers within the defect center (Figure 4H). Further confir-
mation of small nerve fiber sprouting along the bone defect
edge was obtained using immunohistochemical stains for the
pan-neuronal marker PGP9.5 (Figure 4J). In order to further typify
the sprouting nerves, additional immunohistochemical stains
were performed for the peptidergic fiber marker CGRP and
sympathetic marker TH (Figures 4K and 4L). Analysis of serial
sections demonstrated that the majority of nerves entering into
the healing bone defect were CGRP+ peptidergic nociceptors
(Figure 4K), while a smaller subset of nerve fibers representedCell Reports 31, 107696, May 26, 2020 5
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OPEN ACCESSTH+ sympathetic fibers (Figure 4L). Nerve fibers closely asso-
ciate with blood vessels during skeletal development and frac-
ture repair (Li et al., 2019; Tomlinson et al., 2016). The spatial
relationship between nerve fibers and blood vessels was interro-
gated by CD31 immunostaining of sections from Thy1-YFP
pan-neuronal reporters. Both in uninjured calvaria and during
defect healing, YFP+ nerve fibers were observed to course in
parallel and close proximity to CD31+ vessels (Figure S2).
Thus, injury-associated Ngf elaboration is associated by subse-
quent neurovascular infiltration of the injured bone, including
predominantly CGRP+ fibers at sites of incipient bone formation.
Disruption ofNgfAttenuates Re-innervation and Impairs
Calvarial Regeneration
We next determined the requirement for Ngf expression for
normal calvarial bone repair. As multiple cell types showed
NGF reporter activity within a defect niche, we first used a lo-
coregional rather than tissue-specific approach for Ngf deletion.
For this, Ngf fl/fl animals were treated within the defect site with
adenovirus encoding Cre recombinase (Ad-Cre), while control
littermates received Ad-GFP as a control. Validation of recombi-
nation was performed using mT/mG animals, in which Ad-Cre
demonstrated significant recombination within the defect site
2 days post-operatively (Figure S3). Healing among Ad-GFP-
and Ad-Cre-treated bone defects was examined over a previ-
ously validated 4 week period (Zhang et al., 2018) (Figure 5).
Results showed a significant reduction in calvarial defect re-
ossification among Ad-Cre-treated Ngf fl/fl bones, as visualized
using a top-down view of mCT reconstruction as well as coronal
cross-sectional images (Figures 5A and 5B). mCT quantification
was performed to assess bone healing using multiple metrics
(Figures 5C–5G). The amount of regenerated bone within the
defect site was quantified as bone volume (BV) (Figure 5C;
31.3% reduction), fractional BV/tissue volume (TV) (Figure 5D;
31.0% reduction), and bone fractional area (BFA) (Figure 5E;
19.0% reduction). In agreement with these findings, a semiquan-
titative bone healing score showed a significant reduction
among Ad-Cre-treated bone defect (Figure 5F). Conversely,
the mean diameter of the remaining non-ossified bone defect
was significantly increased among Ad-Cre-treated samples
(Figure 5G; 205.9% increase in comparison with Ad-GFP con-
trol). In contrast, no change in bone parameters was observed
with Ad-Cre treatment among uninjured calvarial bones within
the same animal (Figure S4).
H&E staining confirmed a significant reduction in calvarial
re-ossification, including a widened distance between bony
fronts (Figures 5H and 5I; black arrowheads indicate original
defect). The frequency of TUBB3+ dendrites within the defect
site of Ngf floxed animals was next assessed (Figures 5J–5L).
TUBB3+ fibers were again noted most prominently at the
healing defect edge (Figure 5J). A dramatic reduction in
TUBB3+ nerve fibers was observed among Ad-Cre-treated de-
fects (Figure 5K), which when quantified demonstrated a
41.5% reduction in mean TUBB3 immunoreactivity within the
defect site (Figure 5L). Vascularity within the bone injury site
was next assessed among Ad-GFP- and Ad-Cre-treated animals
(Figures 5M–5O). A reduction in CD31+ vascular channels was
found within Ad-Cre-treated injury sites (Figures 5M and 5N),6 Cell Reports 31, 107696, May 26, 2020demonstrating a 35.8% decrease in comparison with Ad-GFP
control (Figure 5O). OCN immunohistochemical staining
was next performed and confirmed a significant reduction in
OCN+ osteoblastic numbers with Ad-Cre treatment of Ngf fl/fl
animals (Figures 5P and 5Q), reflecting a 42.9% reduction in
OCN immunostaining (Figure 5R). In sum, locoregional deletion
of Ngf during bone repair led to significant reduction in injury-
associated re-innervation, impaired revascularization, reduced
total osteoblastic activity, and overall a significant delay in
bone defect healing.
Expression of Ngf in LysM-Expressing Cells Is
Necessary for Normal Calvarial Repair
To further assess the requirement for NGF in calvarial defect
repair, we sought to identify the cell type responsible for produc-
tion of this neurotrophin. As reported above (Figures 2L and 2M),
NGF reporter activity was observed in both F4/80+macrophages
and PDGFRa+ stromal cells following calvarial injury. We there-
fore assessed the innervation and bone healing following disrup-
tion of NGF in each of these cell types. Ngf fl/fl animals were
crossed with either LysM-Cre or PDGFRa-CreERT2 lines to yield
Ngf fl/fl;LysM-Cre (Ngf LysM) animals and Ngf fl/fl;PDGFRa-
CreERT2 (Ngf Pdgfra) animals. Ngf fl/fl;mT/mG (Ngf fl/fl) animals
were used as controls (Figure 6). Tamoxifen (TM) was given using
previously validated injection schedules (Xu et al., 2019), and the
same TM protocol was used across all strains to ensure direct
comparability of the results. First, the spatial localization of
PDGFRa and LysM reporter activity was confirmed (Figures
6A–6D). In uninjured bone, bone-lining cells (ecto- and endocra-
nial) showed PDGFRa reporter activity (Figure 6A, appearing
red), while LysM reporter activity was present within cell more
loosely affiliated with the endocranial bone surface (Figure 6C,
appearing red). As anticipated and at d3 post-operatively, both
PDGFRa-expressing and LysM-expressing cells were abundant
in the defect site (Figures 6B and 6D). Validation for Ngf deletion
was performed using NGF immunohistochemistry on calvarial
injury sites within the Ngf fl/fl, Ngf Pdgfra, and Ngf LysM mice (Fig-
ures 6E–6G). NGF immunohistochemical staining (appearing
green) was reduced across both Ngf Pdgfra and Ngf LysM defect
sites, in comparison with Ngf fl/fl control defects. This was
most conspicuous among Ngf LysM defects, which showed
few NGF immunoreactive cells (Figure 6G). Some residual NGF
immunostaining was present within Ngf Pdgfra defect sites, which
as expected was present only in reporter-negative cells
(Figure 6F).
Next, the cell-specific requirements of Ngf in calvaria bone
repair were assessed, using Ngf fl/fl, Ngf Pdgfra, and Ngf LysM
mice. As in prior experiments, frontal bone healing was assessed
over a 4 week period (Figures 6H–6O). Results demonstrated
impaired bone healing amongNgf LysM but notNgf Pdgfra animals.
mCT reconstructions and cross-sectional images demonstrated
impaired re-ossification among Ngf LysM mice only (Figures
6H–6J). Quantitative mCT metrics of bone healing were reduced
among Ngf LysM mice only, including BV (Figure 6K; 33% reduc-
tion), BV/TV (Figure 6L; 35% reduction), BFA (Figure 6M; 28%
reduction), and bone healing score (Figure 6N). Consistent with
this observation, the mean diameter of the bone defect area
was significantly increased among Ngf LysM animals (Figure 6O;
Figure 5. Local Ngf Deletion Impairs Calvarial Bone Defect Repair
Ngf fl/fl animals were locally injected with Ad-GFP or Ad-Cre virus, followed by creation of a 1.8 mm, circular, full-thickness frontal bone defect.
(A and B) mCT reconstructions of the defect site in a top-down view (above) and coronal cross-sectional images (below) amongNgf fl/fl animals locally injected with
either (A) Ad-GFP or (B) Ad-Cre. Analysis performed at d28 post-injury. Margins of original defect are indicated by dashed black or red lines. Black scale bar,
500 mm; white scale bar, 200 mm.
(C–G) mCT quantification of bone healing among Ad-GFP- and Ad-Cre-injected mice, including (C) bone volume (BV), (D) bone volume/tissue volume (BV/TV), (E)
bone formation area (BFA), (F) bone healing score (score), and (G) defect diameter.
(H and I) H&E stain of coronal cross-section of the healing defect site from (H) Ad-GFP- or (I) Ad-Cre-injected mice. Black arrowheads indicate span of initial
defect. Black scale bar, 50 mm.
(J–L) Immunohistochemical staining of TUBB3+ (beta III tubulin) nerve fibers at the defect edge from (J) Ad-GFP- or (K) Ad-Cre-injectedmice, appearing green and
(L) quantification of TUBB3 immunoreactivity within the calvarial defect. Dashed white lines indicate bone edge.
(M–O) Immunohistochemical staining of CD31+ blood vessels at the defect edge from (M) Ad-GFP- or (N) Ad-Cre-injected mice, appearing red, and (O) quan-
tification of CD31 immunoreactivity within the calvarial defect site. Dashed white lines indicate bone edge.
(P–R) Immunohistochemical staining of OCN+ (osteocalcin) osteoblasts from (P) Ad-GFP- or (Q) Ad-Cre-injected mice, appearing cyan, and (R) quantification of
OCN immunoreactivity within the calvarial defect site. Dashed white lines indicate bone edge. White scale bar, 50 mm.
DAPI counterstain appears blue in all images. In graphs, each dot represents a single animal; n = 8 animals per group. yp < 0.05 and yyp < 0.01 in comparison with
Ad-GFP control. Data are represented as mean ± SD. See also Figures S3 and S4.
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OPEN ACCESS39% increase). In contrast, no statistically significant differences
in bone healing were observed between Ngf Pdgfra and Ngf fl/fl
animals.
Histologic examination by H&E staining verified a significant
reduction in re-ossification of injury site among Ngf LysM mice,
as shown by enlarged distances between bony fronts (Figures
6P–6R; black arrowheads indicate original defect). The densityof TUBB3+ nerve fibers within the defect site was next evaluated
(Figures 6S–6V). Frequent TUBB3+ nerve fibers were again found
around the healing bony fronts within Ngf fl/fl and Ngf Pdgfra de-
fects (Figures 6S and 6T). In contrast, a marked reduction in
TUBB3+ nerve fiber frequency was observed within Ngf LysM
mice (Figure 6U). Quantification of TUBB3+ nerve fibers within
the defect span confirmed a 93% reduction within Ngf LysMCell Reports 31, 107696, May 26, 2020 7
Figure 6. Tissue-Specific Deletion of Ngf in LysM-Expressing Cells but Not Pdgfra-Expressing Cells Blunts Calvarial Bone Defect Repair
Tissue-specific deletion ofNgfwas performed using LysM-Cre (Ngf LysM) or Pdgfra-CreERT2 lines (Ngf Pdgfra), and bone healing was compared with Cre animals
(Ngf fl/fl). Healing was assessed using a 1.8 mm, circular, full-thickness frontal bone defect.
(A–D) Location of PDGFRa or LysM reporter activity before and after injury. (A and B) PDGFRa reporter activity (PDGFRa-CreERT2-mGFP, recolored red) within
the uninjured frontal bone and at d3 post-injury. White scale bar, 50 mm. (C and D) LysM reporter activity (LysM-Cre-tdTomato) within the uninjured frontal bone
and at d3 post-injury. White dashed lines indicate bone edges. White scale bar, 50 mm.
(E–G) Validation of Ngf deletion in either PDGFRa-expressing stromal cells (Ngf Pdgfra) or LysM-expressing monocytes/macrophages (Ngf LysM) in comparison
withNgf fl/fl mice, d3 post-injury. NGF immunohistochemistry among (E)Ngf fl/fl control bone defects, (F)Ngf Pdgfra bone defects, or (G)Ngf LysM bone defects. NGF
immunostaining appears green, while reporter activity appears red. White scale bar, 50 mm.
(H–J) mCT reconstructions of the defect site in a top-down view (above) and coronal cross-sectional images (below) among (H)Ngf fl/fl, (I)Ngf Pdgfra, and (J)Ngf LysM
animals. Margins of original defect are indicated by dashed black or red lines. Black scale bar, 500 mm; white scale bar, 200 mm.
(K–O) mCT quantification of bone healing among Ngf fl/fl, Ngf Pdgfra, and Ngf LysM mice including (K) bone volume (BV), (L) bone volume/tissue volume (BV/TV), (M)
bone formation area (BFA), (N) bone healing score (score), and (O) defect diameter.
(legend continued on next page)






OPEN ACCESSanimals (Figure 6V). In sum, Ngf derived from LysM-expressing
monocytes/macrophages is essential for bone defect re-inner-
vation and osseous repair. In contrast, Ngf from PDGFRa-ex-
pressing stromal cells is dispensable for both defect innervation
and bone healing.
TrkA Signaling Is Required for Normal Calvarial
Regeneration
Much like the long bone (Castañeda-Corral et al., 2011), nerve fi-
bers that extend from the trigeminal ganglia to innervate the
calvarium are universally TrkA expressing (Han et al., 2019). In
order to inhibit TrkA, we used a previously validated chemical-
genetic approach, in which TrkA signaling is acutely disrupted
over a defined period of time. TrkAF592A mice are homozygous
for knockin alleles that encode a phenylalanine-to-alanine
substitution in the protein kinase subdomain V, rendering its
catalytic activity sensitive to specific inhibition by the mem-
brane-permeable small molecule 1NMPP1 (Chen et al., 2005).
Previously we have validated the temporal kinetics of 1NMPP1
inhibition in TrkAF592A and verified that 1NMPP1 has no discern-
able direct effects on osteoblastic cells (Tomlinson et al., 2016)
or on bone repair in wild-type animals (Li et al., 2019).
TrkAF592A mice were now subjected to bone defects with or
without 1NMPP1-mediated inhibition of TrkA (Figure 7). Injury
sites were again analyzed 4 weeks after defect creation,
including analysis of innervation, vascularization, and ossifica-
tion within the healing bone. mCT demonstrated a reduction in
defect re-ossification among 1NMPP1-treated animals at d28
(Figures 7A and 7B). Quantitative mCT metrics of bone formation
demonstrated a significant reduction in all parameters among
1NMPP1-treated animals (Figures 7C–7G). This included reduc-
tions inBV (Figure 7C; 47.5% reduction), fractional BV (Figure 7D;
47.2% reduction), BFA (Figure 7E; 19.5% reduction), and semi-
quantitative bone healing score (Figure 7F) and an increase in re-
maining non-ossified diameter of the defect (Figure 7G; 120.7%
increase in comparison with vehicle control). In contrast, mCT
analysis of uninjured frontal bones was without detectable
change among 1NMPP1-treated TrkAF592A animals (Figure S5).
H&E staining confirmed a significant reduction in calvarial re-
ossification, including a widened distance between bony fronts
(Figures 7H and 7I; arrowheads indicate original defect size).
The frequency of TUBB3+ dendrites within the callus of control-
and 1NMPP1-treated TrkAF592A;Thy1-YFP animals was next
assessed (Figures 7J–7L). TUBB3+ nerve fibers were again
noted most prominently at the healing defect edge (Figure 7J).
A dramatic reduction in TUBB3+ nerve fibers was observed
among 1NMPP1-treated animals (Figure 7K), which when
quantified demonstrated a 71.2% reduction in mean TUBB3
immunoreactivity within the defect site (Figure 7L). Vascularity
within the bone injury site was next assessed among control-
and 1NMPP1-treated TrkAF592A animals (Figures 7M–7O). A(P–R) H&E stain of coronal cross-section of the healing defect site from (P) Ngf fl/fl
defect. Black scale bar, 50 mm.
(S–V) Immunohistochemical staining of TUBB3+ (beta III tubulin) nerve fibers at th
green, and (V) quantification of TUBB3 immunoreactivity within the calvarial defe
In graphs, each dot represents a single animal. n = 9–11 per group for (K)–(O) and N
Ngf Pdgfra. Data are represented as mean ± SD. See also Figure S5.reduction in CD31+ vascular channels was found within
1NMPP1-treated animals (Figures 7M and 7N), demonstrating
a 54.0%decrease in comparisonwith vehicle control (Figure 7O).
OCN immunohistochemical staining was next performed
and confirmed a significant reduction in OCN+ osteoblastic
numbers with 1NMPP1-treated TrkAF592A animals (Figures 7P
and 7Q), reflecting a 37.2% reduction in OCN immunostaining
(Figure 7R). In aggregate, inhibition of TrkA catalytic activity
over the time course of bone defect repair led to a significant
reduction in injury-associated re-innervation, hampered revas-
cularization, reduced total osteoblastic activity, and led to a
significant delay in bone defect healing.
DISCUSSION
In this study, we used both genetic and immunocytochemical
approaches to characterize the innervation of the mouse skull
and to explore their role in cranial bone healing. Our results in
both homeostatic and injury settings are compatible with the
classic neurotropic model, in which acute NGF induction in the
pre-innervated tissue directs the spatial and temporal ingrowth
of nerves (Reichardt, 2006). In this regard, high basal expression
of Ngf in patent suture mesenchyme appears to drive nerve
ingrowth or promote nerve survival at the suture sites. In the
case of calvarial injury, expression of Ngf among defect-associ-
ated monocytes/macrophages appears to be responsible for
directing tissue re-innervation. Our observations are generally
analogous to the sequence of events associated with sensory
innervation of mouse long bones, in which induction of Ngf in
perichondrial mesenchymal cells directs sensory nerves to re-
gions of incipient mineralization (Tomlinson et al., 2016).
Our finding that sensory nerve regrowth is critical for cranial
bone repair is compatible conceptually with a large literature
supporting the importance of sensory nerves in regeneration of
lower order species. For example, the regeneration of limbs of
certain starfish and amphibians, and healing of scales and bar-
bells of fish, are all nerve-dependent processes (Huet, 1975; Ku-
mar et al., 2007; Simões et al., 2014). However, in contrast to the
classic neurotropic model, which stipulates that Ngf production
is highly restricted, neurotrophin production following injury
is more ubiquitous because of the production by invading
inflammatory cells. In this setting, defect-associated mono-
cytes/macrophages appear to be the primary cell mediator of
Ngf-dependent nerve regrowth. Although not specifically ad-
dressed, it is possible that Ngf-expressing macrophages
observed in our study represent osteal macrophages or ‘‘osteo-
macs,’’ which are known regulators of both membranous and
endochondral bone formation (Batoon et al., 2019). The distinc-
tion between NGF expression in tissue-resident and circulatory
monocytes/macrophages would be an interesting avenue for
future study. Our observations of macrophage-dependent, (Q) Ngf Pdgfra, and (R) Ngf LysM mice. Black arrowheads indicate span of initial
e defect edge from (S) Ngf fl/fl, (T) Ngf Pdgfra, and (U) Ngf LysM mice, appearing
ct. Dashed white lines indicate bone edge. White scale bar, 50 mm.
= 7 per group for (V). yp < 0.05 and yyyp < 0.001 in comparison withNgf fl/fl and
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Figure 7. TrkA Inhibition Impairs Calvarial Bone Defect Repair
TrkAF592A animals were treated systemically with 1NMPP1 (or vehicle control) to temporally inhibit TrkA catalytic activity, followed by creation of a 1.8 mm,
circular, full-thickness frontal bone defect.
(A and B) mCT reconstructions of the defect site in a top-down view (above) and coronal cross-sectional images (below) among TrkAF592A animals treated with (A)
vehicle control or (B) 1NMPP1. Black scale bar, 500 mm;white scale bar, 200 mm. Analysis performed at d28 post-injury. Margins of original defect are indicated by
dashed black or red lines.
(C–G) mCT quantification of bone healing, among vehicle control or 1NMPP1-injected mice, including (C) bone volume (BV), (D) bone volume/tissue volume (BV/
TV), (E) bone formation area (BFA), (F) bone healing score (score), and (G) defect diameter.
(H and I) H&E stain of representative coronal cross-section of the healing defect site from (H) vehicle control and (I) 1NMPP1-injected mice. Black arrowheads
indicate span of initial defect. Black scale bar, 50 mm.
(J–L) Immunohistochemical staining of TUBB3+ (beta III tubulin) nerve fibers at the defect edge from (J) vehicle control and (K) 1NMPP1-injected mice, appearing
green, and (L) quantification of TUBB3 immunoreactivity within the calvarial defect. Dashed white lines indicate bone edge.
(M–O) Immunohistochemical staining of CD31+ blood vessels at the defect edge from (M) vehicle control and (N) 1NMPP1-injected mice, appearing red, and (O)
quantification of CD31 immunoreactivity within the calvarial defect site. Dashed white lines indicate bone edge.
(P–R) Immunohistochemical staining of OCN+ (osteocalcin) osteoblasts from (P) vehicle control and (Q) 1NMPP1-injected mice, appearing cyan, and (R)
quantification of OCN immunoreactivity within the calvarial defect site. Dashed white lines indicate bone edge. White scale bar, 50 mm.
DAPI counterstain appears blue in all images. In graphs, each dot represents a single animal; n = 9 per group. yp < 0.05 and yyp < 0.01 in comparison with vehicle
control. Data are represented as mean ± SD.
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OPEN ACCESSsensory re-innervation have some support inmodels ofWallerian
degeneration, in which strain-specific differences in macro-
phage recruitment in mice were linked to differences in sensory
axon regeneration (Brown et al., 1991). In the context of the
skeleton, our observations are in line with Ngf expression by
macrophages in osteoarthritis (Takano et al., 2016, 2017) and10 Cell Reports 31, 107696, May 26, 2020suggest common pathophysiologic mechanisms between scle-
rotic bone changes in osteoarthritis and the anabolic response
to bone injury.
An important question that remains to be addressed is the
downstream molecular mechanisms that mediate neuroskeletal
intercommunication. In particular, the secondary messengers
Article
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OPEN ACCESSreleased by nociceptive fibers that regulate skeletal repair. In
some regenerative contexts, clear nerve-derived factors have
been elucidated. For example and in the salamander blastema,
the anterior gradient protein family member nAG is secreted
from nerve fibers and activates its receptor Prod 1 on blastemal
cells during epimorphic regeneration (Kumar et al., 2007).
Various other candidate nerve-derived molecules have been
examined in amphibian limb regeneration, including FGFs (fibro-
blast growth factors), BMPs (bone morphogenetic proteins),
GGF (glial growth factor), and neurogelin (Brockes and Kintner,
1986; Farkas et al., 2016; Kumar et al., 2007; Makanae et al.,
2016; Mullen et al., 1996). In our prior observations, activation
of neurons within the long bone PO is necessary for mechanical
load-induced Wnt signaling activity (Tomlinson et al., 2017).
Nevertheless, the exact physiologically important secondary
signals released from peptidergic nerve fibers within a bone
injury site remain unknown and are the subject of continued
investigation.
Our findings raise the intriguing possibility that sensory
nerve signaling might be activated to induce bone repair. The
concept that nerve-derived signals could be pro-regenerative
is certainly supported by studies in amphibians, in which surgi-
cal rerouting of nerve branches can prompt formation of an
accessory limb (Maden and Holder, 1984). Delivery of recombi-
nant Ngf itself, however, would represent a pain-evoking stim-
ulus (Hefti, 2020). Moreover, Ngf is susceptible to proteolytic
degradation and has a short elimination half-life (Angeletti
et al., 1972; Friden et al., 1993; Tria et al., 1994) and is likely
not suitable for clinical translation. In a recent report in murine
long bone fracture repair, the TrkA agonist gambogic amide
(GA) was observed to speed fracture repair (Johnstone et al.,
2019). These recent observations provide proof in principle of
the pro-regenerative properties of TrkA signaling, which may
be harnessed to drive re-innervation, revascularization, and
ultimately repair of the mammalian skeleton. The close associ-
ation of nerves and vessels observed here suggests as well that
perivascular precursor cells that contribute to endochondral
bone repair (Maes et al., 2010) may likewise be in close prox-
imity to nerve fibers within healing membranous bones.
Methods to induce tissue re-innervation without activating
pain pathways would be essential for a logical translational
approach of the present findings.
On the other hand, it is important to note that skeletal
sensory nerves function in both skeletal nociception and
anabolism. Consequently, any pharmacological approach to
altering sensory nerve function might be expected to affect
bone anabolism. This has already been observed in human
patients, in whom neutralizing Ngf antibodies predispose to
an unusually high rate of subchondral insufficiency fractures
that come to clinical attention (Hochberg, 2015). Similarly,
missense and nonsense mutations in TRKA (NTRK1) are the
cause of CIPA (congenital insensitivity to pain with anhidrosis)
syndrome (Indo et al., 1996), characterized in part by delayed
fracture healing (Bonkowsky et al., 2003; Toscano et al.,
2000). These lines of evidence point to the interrelated nature
of pain sensation and skeletal repair in human patients and
the central importance of NGF-TrkA signaling in these linked
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Antibodies
Rabbit monoclonal Anti-Axin 2 Abcam Cat# ab109307; RRID:AB_10862550
Rabbit polyclonal Anti-CD31 Abcam Cat# ab28364; RRID:AB_726362
Rat monoclonal Anti-CD45 BioLegend Cat# 103144; RRID:AB_2563458
Rabbit Anti-Calcitonin Gene Related Peptide Sigma-Aldrich Cat# C8198; RRID:AB_259091
Rat monoclonal Anti-F4/80 Abcam Cat# ab204467; RRID:AB_2810932
Rabbit polyclonal Anti-Human Gli1 Abcam Cat# ab49314; RRID:AB_880198
Rabbit polyclonal Anti-IL-1 beta Abcam Cat# ab9722; RRID:AB_308765
Rabbit polyclonal Anti-NGF Abcam Cat# ab6199; RRID:AB_2152414
Rabbit polyclonal Anti-Osteocalcin Abcam Cat# ab93876; RRID:AB_10675660
Rabbit polyclonal Anti-PDGF receptor alpha Abcam Cat# ab15501; RRID:AB_301910
Rabbit polyclonal Anti-PGP 9.5 Agilent Tech Cat# Z511601-2
Rabbit polyclonal Anti-TNF alpha Abcam Cat# ab6671; RRID:AB_305641
Rabbit polyclonal Anti-neuron specific beta III Tubulin Abcam Cat# ab18207; RRID:AB_444319
Goat Anti-Mouse IgG H&L (Alexa Fluor 647)
preadsorbed antibody
Abcam Cat# ab150119; RRID:AB_2811129
DyLight 594 Anti-Rabbit IgG (H+L), made in
goat antibody
Vector Laboratories Cat# DI-1594; RRID:AB_2336413
Bacterial and Virus Strains
Human Adenovirus Type5 (dE1/E3) Vector Biosystems Cat# 1045, Ad-CMV-iCre
Human Adenovirus Type5 (dE1/E3) Vector Biosystems Cat# 1060, Ad-GFP
Chemicals, Peptides, and Recombinant Proteins
Small molecule 1NMPP1 Aurora Analytics Cat# N 0001
DAPI mounting solution Vector Laboratories Vectashield H-1500
14% Ethylenediaminetetraacetic acid Sigma-Aldrich Cat# E6511
Critical Commercial Assays
NF-KappaB Pathway Sampler Kit - 1 Kit Cell Signaling 9936T
iScript cDNA Synthesis Kit Bio-Rad Cat# 1708891
Experimental Models: Organisms/Strains
Mouse: C57BL/6J The Jackson Laboratory Stock #000664
Mouse: mT/mG The Jackson Laboratory Stock #007576
Mouse: TdTomato Donated from Cao laboratory,
Jackson Laboratory
Stock #007914
Mouse: NGF-eGFP Donated from Kawaja laboratory N/A
Mouse: Ngf fl/fl Donated from Minichiello laboratory N/A
Mouse: Thy1-YFP The Jackson Laboratory Stock #003709
Mouse: TrkAF592A Donated from Ginty laboratory,
Jackson Laboratory
Stock #022362
Mouse: Pdgfra-CreERT2 Donated from Bergles laboratory,
Jackson Laboratory
Stock #018280
Mouse: LysM-Cre Jackson Laboratory Stock #004781
Oligonucleotides
Primer: Gapdh Forward: 50- GAC TTC AAC AGC
AAC TCC CAC 30
Thermo Scientific N/A
Primer: Gapdh Reverse: 50- TCC ACC CTG TTG
CTG TA 30
Thermo Scientific N/A
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Primer: Ngf Forward: 50-
ACACTCTGATCACTGCGTTTTTG 30
Thermo Scientific N/A
Primer: Ngf Reverse: 50-
CCTTCTGGGACATTGCTATCTGT-30
Thermo Scientific N/A
Primer: eGFP Forward: 50-
CAACCACTACCTGAGCACCC 30
Thermo Scientific N/A




Leica DM6 Leica Microsystems Inc. https://www.leica-microsystems.com/




NRecon software 2.0.4.0 Bruker SkyScan https://www.bruker.com/
CTVox & CTAn software 1.13 Bruker SkyScan https://www.bruker.com/
Photoshop CC, 2017 Adobe https://www.adobe.com/





Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, AaronW.
James (awjames@jhmi.edu).
Materials Availability
This study did not generate new unique reagents.
Data and Code Availability
The published article includes all datasets generated or analyzed during this study.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
All animals were housed and procedures performed under approval of the Animal Care and Use Committee (ACUC) of The Johns
Hopkins University (MO16M226 &MO19M366). Mouse lines are summarized in Key Resource Table. NGF-eGFPmice were donated
by the Kawaja laboratory, which express eGFP under the control of the mouse NGF promoter (Kawaja et al., 2011). Mice with floxed
Ngf alleles were generated in the Minichiello laboratory (M€uller et al., 2012). Thy1-YFP mice were used as a pan-neuronal reporter,
which harbor a transgene derived from the mouse Thy1 gene that directs expression of YFP in motor and sensory neurons (Feng
et al., 2000). TrkAF592A mice were donated from the Ginty laboratory, which are homozygous for a phenylalanine-to-alanine point mu-
tation in exon 12 of the mouse Ntrk1 gene (F592A) (Chen et al., 2005). This point mutation in TrkAF592A mice renders the endogenous
TrkA kinase sensitive to inhibition by the membrane-permeable small molecule 1NMPP1 (Chen et al., 2005). PDGFRa-CreERT2 mice
were donated from the Bergles laboratory and high specificity of PDGFRa reporter activity has been previously validated (Kang et al.,
2010; Xu et al., 2019). LysM-Cre mice were purchased from the Jackson Laboratory (Strain #004781, Bar Harbor, ME). PDGFRa-
CreERT2 mice were crossed with mT/mG strains to generate PDGFRa-CreERT2;mT/mG reporter animals. LysM-Cre mice were
crossed with mT/mG or tdTomato strains to yield LysM-Cre;mT/mG or LysM-Cre;tdTomato mice. Mixed gender, 16 week old ani-
mals were used for all experiments unless otherwise stated. Wherever feasible, littermate analysis was performed while blinded
to genotype.
In order to achieve locoregional NGF deletion within the skull, an adenovirus encoding either Cre Recombinase (Ad-Cre, 1045-HT.
Vector Biosystems, Malvern, PA) or GFP (Ad-GFP, 1060-HT, Vector Biosystems) was injected percutaneously overlying the
calvaria in mice with NGF floxed alleles (M€uller et al., 2012). 1 3 109 PFU particles were diluted in 50 mL normal saline and injected
both 48 hr prior to surgery and 1 hr post-surgery. In select experiments, the spatial distribution of recombination was assessed
using the same protocol of Ad-Cre injection in mT/mG animals (Muzumdar et al., 2007).Cell Reports 31, 107696, May 26, 2020 e2
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mT/mG or PDGFRa-CreERT2;mT/mG animals. After backcrossing, this yielded Ngf fl/fl;LysM-Cre;mT/mG (Ngf LysM) animals and
Ngf fl/fl;PDGFRa-CreERT2;mT/mG (Ngf Pdgfra) animals. Age matched Ngf fl/fl;mT/mG animals (Ngf fl/fl) were used as controls. In order
to control for the potential skeletal effects of tamoxifen (TM), all genotypes were administered TM (150 mg/kg daily for 5 days, i.p.),
and surgery performed after a 14 day chase period as we have previously validated in PDGFRa-CreERT2;mT/mG animals (Wang
et al., 2020; Xu et al., 2019).
In order to achieve temporal inhibition of TrkA catalytic activity in TrkAF592A animals, the small molecule 1NMPP1 was used (Ha-
nefeld et al., 1996) (Aurora Analytics, LLC, Baltimore, MD). Purity (99.2%) was confirmed by HPLC-UV254, and characterization by 1H
NMR (400MHz, DMSO-d6) was consistent with structure. Stock solution was prepared at 200mMby dissolving 1NMPP1 in dimethyl
sulfoxide (DMSO). For 1NMPP1 administration, intraperitoneal (IP) injections were performed 24 h before, 2 h before and 24 h after
calvarial injury using a 5 mM solution at a dosage of 17 ug/g body weight. In all cases, DMSO containing vehicle was used for




Calvarial defect creation was performed based on our prior methods (Chang et al., 2018; Zhang et al., 2018). Before surgery, mice
were given an intraperitoneal injection of analgesic (1 mg/kg buprenorphine SR). Briefly, hair overlying the calvaria was clipped, and
the skin was aseptically prepared using alternating betadine and alcohol scrubs. Mice were anesthetized by isoflurane gas (1%–3%
inh) for the duration of the experiment. After confirming deep anesthesia, a 1 cm sagittal incision was performed over themidline skull
to expose the frontal bone. A 1.8 mmdiameter, full-thickness, circular frontal bone defect was created using amicro surgical drill and
a trephine drill bit. Meticulous care was taken to protect the neighboring sutures and the underlying tissues. Calvarial defect sites
were irrigated with normal saline. Finally, the skin was sutured and the animal was monitored per established postoperative proto-
cols. Skulls were harvested up to 28 d after injury.
Histology and immunohistochemistry
Calvaria were harvested and placed in 4% paraformaldehyde (PFA) at 4C for 24 h. After sequential washes in PBS x 3, samples
were decalcified in 14% EDTA (1:20 volume, Sigma-Aldrich) for 14 d at 4C. Coronal sections of the calvaria were obtained using
cryosections at 10 or 50 mm thickness. For cryosections, samples were cryoprotected in 30% sucrose overnight at 4C before
embedding in OCT (Tissue-Tek 4583, Torrance, CA). Coronal sections were mounted on adhesive slides (TruBond 380, Matsunami,
Bellingham,WA). For immunohistochemistry, sections were washed in PBS x 3 for 10min.When 50 mm sections were used, sections
were next permeabilized with 0.5% Triton-X for 30 min. Next, 5% normal goat serum was applied for 30 min, then incubated in pri-
mary antibodies overnight at 4C in a humidified chamber (see Key Resource Table and Table S1 for a summary of antibodies used).
The following day, slides were washed in PBS, incubated in the appropriate secondary antibody, A594-Goat Anti-Rabbit IgG or Goat
Anti-Mouse IgG, for 1 h at 25C, then mounted with DAPI mounting solution (Vectashield H-1500, Vector Laboratories, Burlingame,
CA). Digital images of these sections were captured with 10-100 3 objectives using upright fluorescent microscopy (Leica DM6,
Leica Microsystems Inc., Buffalo Grove, IL) or confocal microscopy (Zeiss LSM780 FCS, Carl Zeiss Microscopy GmbH, Jena,
Germany).
Whole mount immunofluorescence
In select experiments, skulls from C57BL/6J mice were used for whole mount imaging. Prior to immunostaining, the skin, muscle,
and brain were carefully dissected away from the calvaria under a dissecting microscope, exposing the periosteum and dura mater.
The samples were fixed in 4% PFA overnight at 4C. Samples were then washed with sequential washes in PBS x 3, and permea-
bilized with 0.5% Triton X-100 at room temperature for 30 min. To block non-specific binding, samples were submerged in 1mL of
10% normal goat serum at room temperature for 30 min. The primary antibody was then applied (1 mL of anti-TUBB3 1:1500; anti-
CGRP 1:200; or anti-TH 1:200) overnight at 4C. Samples were then washed sequential washes in PBS x 3, and submerged in the
appropriate secondary antibody (1 mL of A594-Goat Anti- Rabbit IgG, 1:200) for 1 hr at room temperature. Next, calvaria were
washed in PBS x 3 and submerged in PBS in a black, glass bottom PELCO dish (Ted Pella, Inc, Redding, CA) for imaging. Imaging
was performed using the 10x objective lens on a Zeiss LSM780 FCS, Carl Zeiss Microscopy).
Isolation and culture of mouse calvarial cells
Mouse calvarial cells were collected from C57BL/6J or NGF-eGFP embryos at postnatal day 1. Frontal and parietal bones were
subjected to six sequential enzymatic digestions with a mixture containing 1 mg/mL collagenase type I (Worthington Biochemical
Corporation, Lakewood, NJ, USA; LS004197) and 1 mg/mL collagenase type II (Worthington Biochemical Corporation;
LS004177)(Noda et al., 2016). Cell fractions from sequential digestions 3-5 were collected and cultured in a-MEM supplemented
with 15% (vol/vol) FBS, 100 U/mL penicillin, and 100 mg/mL streptomycin. To measure cytokine-induced NGF expression, cells
were treated with recombinant IL-1b (1-50 ng/mL) or TNF-a (1-50 ng/mL) for 48 h, followed by qRT-PCR analysis.e3 Cell Reports 31, 107696, May 26, 2020
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Total RNA was extracted from the cultured cells using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) according to the manufac-
turer’s instructions. 0.8 mg of total RNA was used for reverse transcription with iScript cDNA synthesis kit (Bio-Rad) following
manufacturer’s instructions. Real-time PCR was performed using SYBR Green PCR Master Mix (Thermo Scientific) according to
the manufacturer’s protocol. Specific primers for SYBR green qPCR were verified by using Primer-BLAST from National Center
for Biotechnology Information (NCBI). Standard cycling condition of amplification (primer Tm R 60
C) was performed; UDG activa-
tion, 50C, 2 min; then Dual-LockTM DNA Polymerase, 95C, 2 min; then Denature, 40 cycles of 95C, 15 s; then Anneal / Extend, 40
cycles of 60C, 1 min. Further, specificity of amplification for SYBRgreen-based qPCR was validated by the Melt Curve Plot of each
reaction that the single peak reaction was observed. Relative gene expression was calculated using a 2-DDCt method by normali-
zation with Gapdh. Primer sequences are presented in Key Resource Table.
Western Blot
Mouse calvarial cells were stimulated with IL-1b (1 ng/mL) or TNF-a (25 ng/mL) and lysed in RIPA buffer (Thermo Fisher Scientific)
with protease inhibitor cocktail (Cell Signaling Technologies, Danvers, MA, USA). The separation of proteins was performed using
a 10% gradient SDS-polyacrylamide gel and transferred to a nitrocellulose membrane. The blotted nitrocellulose membranes
were directly blocked with a blocking buffer (5% bovine serum albumin in Tris-buffered saline (TBS) with 0.05% Tween-20 (TBST)
for 1 hr and then probed with primary antibodies (see Key Resource Table and Table S1). After washing with TBST three times,
membranes were incubated with a horseradish-peroxidase (HPR)-conjugated secondary antibody and visualized with ChemiDoc
XRS+ System (Bio-rad, Hercules, CA).
QUANTIFICATION AND STATISTICAL ANALYSIS
MicroCT imaging and analysis
Skulls were dissected free of skin and brain tissue and evaluated using a SkyScan1172 high-resolution microCT imaging
system (Bruker, Kontich, Belgium). Scans were obtained at an image resolution of 10 mm, with the following settings: 1mm of
aluminum filter, X-ray voltage of 65 kVP, anode current of 153 mA, exposure time of 65ms, frame averaging of 5, and rotation step
of 0.3 degrees. Three-dimensional images were then reconstructed from the 2D X-ray projections by implementing the Feldkamp
algorithm using a commercial software package NRecon software (2.0.4.0 SkyScan). For the 3D morphometric analyses of images,
CTVox and CTAn software (1.13 SkyScan) were used.
For calvarial defect analysis, a cylindrical volume of interest centered around each defect site was defined as the 1.6 mm in diam-
eter and 1 mm in height with a threshold value of 80. Bone volume (BV) and tissue volume (TV) measurements were calculated from
analyses performed for a volume of 100 slices. The amount of bone formationwas analyzed and quantified using threemethods. First,
bone volume (BV) and fractional bone volume (bone volume/tissue volume (BV/TV)) were calculated from binary X-ray images. Sec-
ond, bone fractional area (BFA) was calculated by using CTVox to create a 3D rendering of the calvarial defect in a top-down view,
and then measuring pixels of bone within the defect divided by total defect area using Photoshop (Adobe, San Jose, California).
Lastly, a semiquantitative bone healing score from 0 to 4 was assigned by 3 blinded observers according to previous published
grading scales for calvarial defect healing (Spicer et al., 2012). Briefly, the grading system was as follows: 0–no bone formation,
1–few bony spicules dispersed through defect, 2–bony bridging only at defect borders, 3–bony bridging over partial length of defect,
and 4–bony bridging entire span of defect at longest point.
Histologic image analysis
All images for quantification were obtained either with upright fluorescent microscopy (Leica DM6, Leica Microsystems Inc.) or
confocal microscopy (Zeiss LSM780 FCS, Carl Zeiss Microscopy GmbH). NGF-eGFP reporter activity, TUBB3+ nerve fibers,
CD31+ blood vessels, and OCN+ osteoblasts were quantified using either the magic wand tool of Photoshop CC, 2017 with a toler-
ance of 30 (Adobe, San Jose, CA) using five random 40xmicroscopical fields per sample or three-dimensional volumetric analysis of
Imaris software v9.3 (Oxford Instruments, Belfast, UK) using eight serial fields per sample within the defect tissue.
Statistics
Quantitative data are expressed at mean ± SD, with p < 0.05 and p < 0.01 considered significant. The number of samples are indi-
cated in figure legends. A Shapiro-Wilk test for normality was performed on all datasets. Homogeneity was confirmed by a compar-
ison of variances test. Parametric data was analyzed using an appropriate Student’s t test when two groupswere being compared, or
a one-way ANOVA was used when more than two groups were compared, followed by a post hoc Tukey’s test to compare two
groups. Nonparametric data was analyzed with a Mann-Whitney U test when two groups were being compared or a Kruskal-Wallis
one-way analysis when more than two groups were compared. Sample size calculations were performed for experiments presented
in Figures 5, 6, and 7 based on an anticipated effect size of 1.75, using our previously published data in adult TrkAF592A mice (Tom-
linson et al., 2017). For this scenario, with 8 replicates per group a two-sample t test would provide 80% power to detect effect sizes
of at least 1.5 assuming a two-sided 0.05 level of significance.Cell Reports 31, 107696, May 26, 2020 e4
